Advertisement
NeuroScientistNews
NeuroScientistNews

Most Recent

image: Best in Industry, 2012

Best in Industry, 2012

By | June 1, 2012

Whether working for a pharmaceutical giant or a biotech start-up with a unique vision, researchers who responded to this year’s Best Places to Work in Industry survey are translating society’s most pressing scientific needs into a new generation of drugs, research tools, and cutting-edge innovations.

2 Comments

image: Capsule Reviews

Capsule Reviews

By | June 1, 2012

The Aha! Moment, Imagine, Ignorance, and The Age of Insight

0 Comments

image: Book Excerpt from <em>The Mara Crossing</em>

Book Excerpt from The Mara Crossing

By | June 1, 2012

Author Ruth Padel tells the stories of John James Audubon and cellular migration in prose and verse

1 Comment

Contributors

June 1, 2012

Meet some of the people featured in the June 2012 issue of The Scientist.

0 Comments

image: Delivering New Genes

Delivering New Genes

By | June 1, 2012

Gene therapies typically involve the introduction of genetic material into target cells to replace or supplement an existing, usually dysfunctional, gene. 

0 Comments

image: Interfering with Resistance

Interfering with Resistance

By | June 1, 2012

Drug efficacy and resistance mechanisms shine a light on how drugs enter cells, which could facilitate the development of new sleeping-sickness treatments. 

0 Comments

image: Best Places to Work Industry, 2012

Best Places to Work Industry, 2012

By | June 1, 2012

Much has changed in the 10 years since our first survey of industry researchers. Large companies are now looking to small, nimble ones for services as well as innovation.

0 Comments

image: From Bones to Brains

From Bones to Brains

By | June 1, 2012

With the help of a mother, one researcher uncovered a common link between autism and a devastating bone disease.

2 Comments

image: Microbiology Goes High-Tech

Microbiology Goes High-Tech

By | June 1, 2012

Out with toothpicks and pipettors; in with automation.

0 Comments

image: Regulations for Biosimilars

Regulations for Biosimilars

By | June 1, 2012

As biologic drug patents begin to expire, generic versions will hit the market—but how will they be regulated?

2 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement
NeuroScientistNews
NeuroScientistNews

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Advertisement
The Scientist
The Scientist
Life Technologies